View More View Less
  • 1 German Armed Forces Hospital of Hamburg, Hamburg, Germany
  • | 2 CBRN Defence, Safety and Environmental Protection School, Science Division
  • | 3 Bundeswehr Medical Academy, Munich, Germany
  • | 4 Federal Research Institute for Animal Health, Jena, Germany
  • | 5 German Armed Forces Hospital of Hamburg, Hamburg, Germany
  • | 6 University Medicine Rostock, Rostock, Germany
  • | 7 Bundeswehr Medical Academy, Munich, Germany
Open access

Reliable identification of pathogenic Burkholderia spp. like Burkholderia mallei and Burkholderia pseudomallei in clinical samples is desirable. Three different selective media were assessed for reliability and selectivity with various Burkholderia spp. and nontarget organisms.

Mast Burkholderia cepacia agar, Ashdown + gentamicin agar, and B. pseudomallei selective agar were compared. A panel of 116 reference strains and well-characterized clinical isolates, comprising 30 B. pseudomallei, 20 B. mallei, 18 other Burkholderia spp., and 48 nontarget organisms, was used for this assessment.

While all B. pseudomallei strains grew on all three tested selective agars, the other Burkholderia spp. showed a diverse growth pattern. Nontarget organisms, i.e., nonfermentative rod-shaped bacteria, other species, and yeasts, grew on all selective agars. Colony morphology did not allow unambiguous discrimination.

While the assessed selective media reliably allowed the growth of a wide range of B. pseudomallei strains, growth of other Burkholderia spp. is only partially ensured. Growth of various nontarget organisms has to be considered. Therefore, the assessed media can only be used in combination with other confirmative tests in the diagnostic procedure for the screening for melioidosis or glanders.

Supplementary Materials

  • 1.

    Gilad J : Burkholderia mallei and Burkholderia pseudomallei: the causative micro-organisms of glanders and melioidosis. Recent Pat Antiinfect Drug Discov 2, 233241 (2007)

    • Search Google Scholar
    • Export Citation
  • 2.

    Frickmann H , Chantratita N, Gauthier YP, Neubauer H, Hagen RM: Discrimination of Burkholderia mallei/pseudomallei from Burkholderia thailandensis by sequence comparison of a fragment of the ribosomal protein S21 (rpsU) gene. Eur J Microbiol Immunol (Bp) 2, 148156 (2012)

    • Search Google Scholar
    • Export Citation
  • 3.

    Frickmann H , Neubauer H, Loderstaedt U, Derschum H, Hagen RM: rpsU-based discrimination within the genus Burkholderia. Eur J Microbiol Immunol (Bp) 4, 106116 (2014)

    • Search Google Scholar
    • Export Citation
  • 4.

    Ostermann MF , Neubauer H, Frickmann H, Hagen RM: Correlation of rpsU gene sequence clusters and biochemical properties, GC-MS spectra and resistance profiles of clinical Burkholderia spp. isolates. Eur J Microbiol Immunol (Bp) 6, 2539 (2016)

    • Search Google Scholar
    • Export Citation
  • 5.

    Frickmann H , Neubauer H, Haase G, Peltroche-Llacsahuanga H, Pérez-Bouza A, Racz P, Loderstaedt U, Hagen RM: Fatal urosepsis due to delayed diagnosis of genitourinary melioidosis. Laboratoriumsmedizin 37, 209213 (2013)

    • Search Google Scholar
    • Export Citation
  • 6.

    Kingsley PV , Arunkumar G, Tipre M, Leader M, Sathiakumar N: Pitfalls and optimal approaches to diagnose melio idosis. Asian Pac J Trop Med 9, 515524 (2016)

    • Search Google Scholar
    • Export Citation
  • 7.

    Hemarajata P , Baghdadi JD, Hoffman R, Humphries RM: Burkholderia pseudomallei: challenges for the clinical microbiology laboratory. J Clin Microbiol 54, 28662873 (2016)

    • Search Google Scholar
    • Export Citation
  • 8.

    Lau SK , Sridhar S, Ho CC, Chow WN, Lee KC, Lam CW, Yuen KY, Woo PC: Laboratory diagnosis of melioidosis: past, present and future. Exp Biol Med (Maywood) 240, 742751 (2015)

    • Search Google Scholar
    • Export Citation
  • 9.

    Baldwin A , Mahenthiralingam E, Thickett KM, Honeybourne D, Maiden MC, Govan JR, Speert DP, LiPuma JJ, Vandamme P, Dowson CG: Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex. J Clin Microbiol 43, 46654673 (2005)

    • Search Google Scholar
    • Export Citation
  • 10.

    Lynch KH , Dennis JJ: Development of a species-specific fur gene-based method for identification of the Burkholderia cepacia complex. J Clin Microbiol 46, 447455 (2008)

    • Search Google Scholar
    • Export Citation
  • 11.

    Papaleo MC , Perrin E, Maida I, Fondi M, Fani R, Vandamme P: Identification of species of the Burkholderia cepacia complex by sequence analysis of the hisA gene. J Med Microbiol 59, 11631170 (2010)

    • Search Google Scholar
    • Export Citation
  • 12.

    Payne GW , Vandamme P, Morgan SH, LiPuma JJ, Coenye T, Weightman AJ, Jones TH, Mahenthiralingam E: Development of a recA gene-based identification approach for the entire Burkholderia genus. Appl Env Microbiol 71, 39173927 (2005)

    • Search Google Scholar
    • Export Citation
  • 13.

    Cesarini S , Bevivino A, Tabacchioni S, Chiarini L, Dalmastri C: RecA gene sequence and multilocus sequence typing for species-level resolution of Burkholderia cepacia complex isolates. Lett Appl Microbiol 49, 580588 (2009)

    • Search Google Scholar
    • Export Citation
  • 14.

    Karger A , Stock R, Ziller M, Elschner MC, Bettin B, Melzer F, Maier T, Kostrzewa M, Scholz HC, Neubauer H, Tomaso H: Rapid identification of Burkholderia mallei and Burkholderia pseudomallei by intact cell matrix-assisted laser desorption/ionisation mass spectrometry typing. BMC Microbiol 12, 229 (2012)

    • Search Google Scholar
    • Export Citation
  • 15.

    Degand N , Carbonelle E, Dauphin B, Beretti JL, Le Bourgeois M, Sermet-Gaudelus I, Segonds C, Berche P, Nassif X, Ferroni A: Matrix-assisted laser desorption ionizationtime of flight mass spectrometry for identification of nonfermenting gram-negative bacilli isolated from cystic fibrosis patients. J Clin Microbiol 46, 33613367 (2008)

    • Search Google Scholar
    • Export Citation
  • 16.

    Vanlaere E , Sergeant K, Dawyndt P, Kallow W, Erhard M, Sutton H, Dare D, Devreese B, Samyn B, Vandamme P: Matrix-assisted laser desorption ionisation-time-of-flight mass spectrometry of intact cells allows rapid identification of Burkholderia cepacia complex. J Microbiol Methods 75, 279286 (2008)

    • Search Google Scholar
    • Export Citation
  • 17.

    Minan A , Bosch A, Lasch P, Stammler M, Serra DO, Degrossi J, Gatti B, Vay C, D’aquino M, Yatorno O, Naumann D: Rapid identification of Burkholderia cepacia complex species including strains of the novel Taxon K, recovered from cystic fibrosis patients by intact cell MALDI-ToF mass spectrometry. Analyst 134, 11381148 (2009)

    • Search Google Scholar
    • Export Citation
  • 18.

    Micheel V , Hogan B, Köller T, Warnke P, Crusius S, Hinz R, Hagen RM, Schwarz NG, Frickmann H: Screening agars for MRSA: evaluation of a stepwise diagnostic approach with two different selective agars for the screening for methicillin-resistant Staphylococcus aureus (MRSA). Mil Med Res 2, 18 (2015)

    • Search Google Scholar
    • Export Citation
  • 19.

    Micheel V , Hogan B, Rakotoarivelo RA, Rakotozandrindrainy R, Razafimanatsoa F, Razafindrabe T, Rakotondrainiarivelo JP, Crusius S, Poppert S, Schwarz NG, May J, Frickmann H, Hagen RM: Identification of nasal colonization with ß-lactamase-producing Enterobacteriaceae in patients, health care workers and students in Madagascar. Eur J Microbiol Immunol (Bp) 5, 116125 (2015)

    • Search Google Scholar
    • Export Citation
  • 20.

    Howard K , Inglis TJ: Novel selective medium for isolation of Burkholderia pseudomallei. J Clin Microbiol 41: 33123316 (2003)

  • 21.

    Ashdown LR : An improved screening technique for isolation of Pseudomonas pseudomallei from clinical specimens. Pathology 11, 293297 (1997)

    • Search Google Scholar
    • Export Citation
  • 22.

    Henry DA , Campbell ME, LiPuma JJ, Speert DP: Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium. J Clin Microbiol 35, 614619 (1997)

    • Search Google Scholar
    • Export Citation
  • 23.

    Roesnita B , Tay ST, Puthucheary SD, Sam IC: Diagnostic use of Burkholderia pseudomallei selective media in a low prevalence setting. Trans R Soc Trop Med Hyg 106, 131133 (2012)

    • Search Google Scholar
    • Export Citation
  • 24.

    Peacock SJ , Chieng G, Cheng AC, Dance DA, Amornchai P, Wongsuvan G, Teerawattanasook N, Chierakul W, Day NP, Wuthiekanun V: Comparison of Ashdown’s medium, Burkholderia cepacia medium, and Burkholderia pseudomallei selective agar for clinical isolation of Burkholderia pseudomallei. J Clin Microbiol 43, 53595361 (2005)

    • Search Google Scholar
    • Export Citation
  • 25.

    Glass MB , Beesley CA, Wilkins PP, Hoffmaster AR: Comparison of four selective media for the isolation of Burkholderia mallei and Burkholderia pseudomallei. Am J Trop Med Hyg 80, 10231028 (2009)

    • Search Google Scholar
    • Export Citation
  • 26.

    Vermis K , Vandamme PA, Nelis HJ: Burkholderia cepacia complex genomovars: utilization of carbon sources, susceptibility to antimicrobial agents and growth on selective media. J Appl Microbiol 95, 11911199 (2003)

    • Search Google Scholar
    • Export Citation
  • 27.

    Wright RM , Moore JE, Shaw A, Dunbar K, Dodd M, Webb K, Redmond AO, Crowe M, Murphy PG, Peacock S, Elborn JS: Improved cultural detection of Burkholderia cepacia from sputum in patients with cystic fibrosis. J Clin Pathol 54, 803805 (2001)

    • Search Google Scholar
    • Export Citation
  • 28.

    Welch DF , Muszynski MJ, Pai CH, Marcon MJ, Hribar MM, Gilligan PH, Matsen JM, Ahlin PA, Hilman BC, Chartrand SA: Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis. J Clin Microbiol 25, 17301734 (1987)

    • Search Google Scholar
    • Export Citation
  • 29.

    Henry D , Campbell M, McGimpsey C, Clarke A, Louden L, Burns JL, Roe MH, Vandamme P, Speert D: Comparison of isolation media for recovery of Burkholderia cepacia complex from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol 37: 10041007 (1999)

    • Search Google Scholar
    • Export Citation
  • 30.

    Cimolai N , Trombley C, Davidson AG, Wong LT: Selective media for isolation of Burkholderia (Pseudomonas) cepacia from the respiratory secretions of patients with cystic fibrosis. J Clin Pathol 48, 488490 (1995)

    • Search Google Scholar
    • Export Citation
  • 31.

    Flanagan PG , Paull A: Isolation of Burkholderia cepacia by enrichment. J Clin Pathol 51, 557558 (1998)

  • 32.

    Raclavsky V , Novotny R: Burkholderia cepacia selective agar can be useful for recovery of Exophiala dermatitidis from sputum samples of cystic fibrosis patients. J Cyst Fibros 15, e19 (2016)

    • Search Google Scholar
    • Export Citation
  • 33.

    Hagen RM , Frickmann H, Elschner M, Melzer F, Neubauer H, Gauthier YP, Racz P, Poppert S: Rapid identification of Burkholderia pseudomallei and Burkholderia mallei by fluorescence in situ hybridization (FISH) from culture and paraffin-embedded tissue samples. Int J Med Microbiol 301, 585590 (2011)

    • Search Google Scholar
    • Export Citation
  • 34.

    Karger A , Stock R, Ziller M, Elschner MC, Bettin B, Melzer F, Maier T, Kostrzewa M, Scholz HC, Neubauer H, Tomaso H: Rapid identification of Burkholderia mallei and Burkholderia pseudomallei by intact cell matrix-assisted laser desorption/ionisation mass spectrometry typing. BMC Microbiol 12, 229 (2012)

    • Search Google Scholar
    • Export Citation
  • 35.

    Vanlaere E , Sergeant K, Dawyndt P, Kallow W, Erhard M, Sutton H, Dare D, Devreese B, Samyn B, Vandamme P: Matrix-assisted laser desorption ionisation-time-of-flight mass spectrometry of intact cells allows rapid identification of Burkholderia cepacia complex. J Microbiol Methods 75, 279286 (2008)

    • Search Google Scholar
    • Export Citation
The author instruction is available in PDF.
Please, download the file from HERE.
 

Senior editors

Editor(s)-in-Chief: Dunay, Ildiko Rita

Editor(s)-in-Chief: Heimesaat, Markus M.

Vice Editor(s)-in-Chief: Fuchs, Anja

Editorial Board

Chair of the Editorial Board:
Jeffrey S. Buguliskis (Thomas Jefferson University, USA)

  • Jörn Albring (University of Münster, Germany)
  • Stefan Bereswill (Charité - University Medicine Berlin, Germany)
  • Dunja Bruder (University of Megdeburg, Germany)
  • Jan Buer (University of Duisburg, Germany)
  • Jeff Buguliskis (Thomas Jefferson University, USA)
  • Edit Buzas (Semmelweis University, Hungary)
  • Charles Collyer (University of Sydney, Australia)
  • Renato Damatta (UENF, Brazil)
  • Ivelina Damjanova (Semmelweis University, Hungary)
  • Maria Deli (Biological Research Center, HAS, Hungary)
  • Olgica Djurković-Djaković (University of Belgrade, Serbia)
  • Jean-Dennis Docquier (University of Siena, Italy)
  • Anna Erdei (Eötvös Loránd University, Hungary)
  • Zsuzsanna Fabry (University of Washington, USA)
  • Beniam Ghebremedhin (Witten/Herdecke University, Germany)
  • Nancy Guillen (Institute Pasteur, France)
  • Georgina L. Hold (University of Aberdeen, United Kingdom)
  • Ralf Ignatius (Charité - University Medicine Berlin, Germany)
  • Zsuzsanna Izsvak (MDC-Berlin, Germany)
  • Achim Kaasch (University of Cologne, Germany)
  • Tamás Laskay (University of Lübeck, Germany)
  • Oliver Liesenfeld (Roche, USA)
  • Shreemanta Parida (Vaccine Grand Challenge Program, India)
  • Matyas Sandor (University of Wisconsin, USA)
  • Ulrich Steinhoff (University of Marburg, Germany)
  • Michal Toborek (University of Miami, USA)
  • Mary Jo Wick (University of Gothenburg, Sweden)
  • Susanne A. Wolf (MDC-Berlin, Germany)

 

Dr. Dunay, Ildiko Rita
Magdeburg, Germany
E-mail: ildikodunay@gmail.com

Indexing and Abstracting Services:

  • PubMed Central
  • Scopus
  • ESCI
  • CABI

 

2020  
CrossRef Documents 23
WoS Cites 708
Wos H-index 27
Days from submission to acceptance 219
Days from acceptance to publication 176
Acceptance Rate 70%

2019  
WoS
Cites
558
CrossRef
Documents
24
Acceptance
Rate
92%

 

European Journal of Microbiology and Immunology
Publication Model Gold Open Access
Submission Fee none
Article Processing Charge 928 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription Information Gold Open Access
Purchase per Title  

European Journal of Microbiology and Immunology
Language English
Size A4
Year of
Foundation
2011
Publication
Programme
2021 Volume 11
Volumes
per Year
1
Issues
per Year
4
Founder Akadémiai Kiadó
Founder's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 2062-509X (Print)
ISSN 2062-8633 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Apr 2021 0 3 2
May 2021 0 8 7
Jun 2021 0 7 5
Jul 2021 0 2 2
Aug 2021 0 4 7
Sep 2021 0 6 5
Oct 2021 0 2 0